Thermal Ablation versus SBRT in liver tumours: pros and cons.


Journal

Medical oncology (Northwood, London, England)
ISSN: 1559-131X
Titre abrégé: Med Oncol
Pays: United States
ID NLM: 9435512

Informations de publication

Date de publication:
29 Apr 2020
Historique:
received: 17 02 2020
accepted: 16 04 2020
entrez: 1 5 2020
pubmed: 1 5 2020
medline: 1 12 2020
Statut: epublish

Résumé

Non-surgical locally ablative treatments for primary liver cancer and liver metastases represent an effective therapeutic choice when surgery cannot be performed or is not indicated. Thermal ablative employing electric currents or electromagnetic fields have historically played an important role in this setting. Radiotherapy, in the last decades, due to a series of important technological development, has become an attractive option for the treatment of liver tumours, especially with the introduction of Stereotactic Body Radiotherapy. Published literature so far evidenced both for radiotherapy and thermal ablative techniques a benefit in terms of local control and other oncological outcomes; however, no direct prospective comparison between the two techniques have been published so far. The aim of this review is to summarize the technical and clinical implications of these treatment modalities and to identify criteria to allocate patients to one or another option in consideration of the expected efficacy. The main features and critical aspects of both thermoablative techniques and external beam radiation will also be covered in the present paper.

Identifiants

pubmed: 32350765
doi: 10.1007/s12032-020-01377-7
pii: 10.1007/s12032-020-01377-7
doi:

Types de publication

Comparative Study Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

52

Auteurs

Mauro Loi (M)

Radiotherapy Department, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Isacco Desideri (I)

Radiotherapy Department, University of Florence, Largo Brambilla 3, 50134, Florence, Italy. isacco.desideri@unifi.it.

Luca Dominici (L)

Radiotherapy Department, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Giulio Francolini (G)

Radiotherapy Department, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Pietro Garlatti (P)

Radiotherapy Department, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Lucia Pia Ciccone (LP)

Radiotherapy Department, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Giulia Stocchi (G)

Radiotherapy Department, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Viola Salvestrini (V)

Radiotherapy Department, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Icro Meattini (I)

Radiotherapy Department, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Lorenzo Livi (L)

Radiotherapy Department, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH